'Natalizumab in paediatric multiple sclerosis and service implication'

Developmental Medicine and Child Neurology

Volumn 51, Issue 9, 2009, Pages 758-759

  Appleton, Richard E ^a   Boggild, Mike ^b  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLATIRAMER; METHYLPREDNISOLONE; NATALIZUMAB; OLIGOCLONAL BAND;

BRAIN DAMAGE; CASE REPORT; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILD CARE; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENCEPHALOMYELITIS; HUMAN; LETTER; MALE; MONOCYTE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHOOL CHILD;

ANTIBODIES, MONOCLONAL; CHILD; HUMANS; MALE; MULTIPLE SCLEROSIS;

EID: 68549121083     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2009.03378.x     Document Type: Letter

References (10)

1. Karenfort M, Kieseier BC, Tibussek D, Assmann B, Schaper J, Mayatepek E. Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis. Dev Med Child Neurol 2009; 51: 159-61.
2. Ruggieri M, Polizzi A, Pavone L, et al. Multiple sclerosis in children under 6 years of age. Neurology 1999; 53: 478-84.
3. Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009; 66: 54-59.
4. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-27.
5. National Institute for Clinical Excellence. Beta Interferon and Glatiramer Acetate for the Treatment of Multiple Sclerosis: Technology Appraisal Number 32, 2002. http://www.nice.org.uk (accessed November 2008).
6. Huppke P, Stark W, Zurcher C, Huppke B, Bruck W, Gartner J. Natalizumab use in pediatric multiple sclerosis. Arch Neurol 2008; 65: 1655-58.
7. Borriello G, Prosperini L, Luchetti A, Pozzilli C. Natalizumab treatment in pediatric multiple sclerosis: A case report. Eur J Paediatr Neurol 2009; 13: 67-71.
8. Multiple Sclerosis Society. Paediatric Multiple Sclerosis: A Report from an MS Society Workshop. London: MS National Centre, 2008.
9. Appleton RE. Epilepsy in the teenager. Paediatr Child Health 2009; 19: 232-35.
10. National Service Framework. Improving the transition of young people with long term conditions from children's to adult health services. 'Transition: Getting it right for young people' (best practice guideline). London: Department of Health, 2006. http://www.dh.gov.uk/en/ Policyandguidance/Healthandsocialservicecaretopics/Childrenservices/ Transitionfromchildrentoadultservices/index (accessed November 2008).